Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Interim Management Statement

31st Oct 2011 07:00

RNS Number : 1074R
Barclays PLC
31 October 2011
 



 

31 October 2011

Barclays PLC - Interim Management Statement

''I am pleased with the performance we have delivered for the first nine months of the year, with profit before tax exceeding £5bn, despite significant economic and market headwinds. These results demonstrate the continued progress towards our 2013 goals through building momentum across retail and corporate banking businesses and strong relative performance by Barclays Capital in difficult market conditions. Our focus on cost reduction continues to deliver results and we are confident that we will exceed the £1bn savings target we set earlier this year.

Our profits before tax have been generated equally across our retail and investment banking businesses, showing the diversity and balance of Barclays. Rock solid capital, funding, and liquidity have been maintained. We will continue to generate sufficient capital for our business needs and do not intend to raise new equity capital. We remain committed to lending in the UK and are on track to exceed our Merlin goals.''

Bob Diamond, Chief Executive

 

Group Unaudited Results  

30.09.11

30.09.10

£m

£m

% Change

Total income net of insurance claims excluding own credit

22,242 

22,968 

(3)

Own credit gain/(charge)

2,971 

(96)

nm

Total income net of insurance claims

25,213 

22,872 

10 

Credit impairment charges and other provisions

(2,851)

(4,298)

(34)

Impairment of investment in BlackRock, Inc.

(1,800)

nm

Net operating income

20,562 

18,574 

11 

Operating expenses excluding provision for payment protection insurance (PPI) redress

(14,488)

(14,476)

Provision for PPI redress1 

(1,000)

nm

Profit before tax

5,066 

4,274 

19 

Own credit (gain)/charge

(2,971)

96 

nm

Impairment of investment in BlackRock, Inc.

1,800 

nm

Provision for PPI redress1 

1,000 

nm

Losses/(gains) on acquisitions and disposals2 

120 

(134)

nm

Adjusted profit before tax

5,015 

4,236 

18 

Profit after tax

3,349 

3,206 

Profit attributable to equity holders of the parent

2,651 

2,480 

Basic earnings per share

22.2p

21.3p

Dividend per share

3.0p

3.0p

Capital and Balance Sheet  

30.09.11

30.06.11

Core Tier 1 ratio

11.0%

11.0%

nm

Risk weighted assets

£390bn

£395bn

(1)

Adjusted gross leverage

21x

20x

nm

Group liquidity pool

£166bn

£145bn

14 

Net asset value per share

439p

423p

Net tangible asset value per share

372p

353p

Group loan: deposit ratio

116%

118%

nm

 

Adjusted3 

Statutory

Performance Measures  

30.09.11

30.09.10

30.09.11

30.09.10

Return on average shareholders' equity

8.1%

6.5%

6.9%

6.7%

Return on average tangible shareholders' equity

9.7%

7.9%

8.3%

8.1%

Return on average risk weighted assets

1.3%

1.0%

1.1%

1.1%

Cost: income ratio

65%

63%

61%

63%

Cost: net operating income ratio

74%

78%

75%

78%

 

 

 

 

 

 

1 Provision for the settlement of PPI claims following the conclusion of the Judicial Review proceedings. In addition the Group has recognised costs of £13m (2010: 155m) for the settlement of PPI claims unrelated to the Judicial Review

2 2011 includes a £58m loss on disposal of a portion of the Group's strategic investment in BlackRock, Inc. recycled through investment income, and a

£64m provision relating to the sale of Barclays Bank Russia

3 Adjusted performance metrics and profit before tax reflect the adjusting items disclosed above

Q311 Interim Management Statement

Group Performance

Group Results by Quarter

Q311

Q211

Q111

Q410

Q310

Q210

Q110

 

£m

£m

£m

£m

£m

£m

£m

 

Total income net of insurance claims (excluding own credit)

7,001 

7,491 

7,750 

8,081 

7,238 

7,563 

8,167 

 

Own credit gain/(charge)

2,882 

440 

(351)

487 

(947)

953 

(102)

 

Total income net of insurance claims

9,883 

7,931 

7,399 

8,568 

6,291 

8,516 

8,065 

 

Credit impairment charges and other provisions

(1,023)

(907)

(921)

(1,374)

(1,218)

(1,572)

(1,508)

 

Impairment of investment in BlackRock, Inc.

(1,800)

 

Net operating income

7,060 

7,024 

6,478 

7,194 

5,073 

6,944 

6,557 

 

Operating expenses (excluding provision for PPI redress)

(4,659)

(4,987)

(4,842)

(5,495)

(4,756)

(4,868)

(4,852)

 

Provision for PPI redress

(1,000)

 

Total operating expenses

(4,659)

(5,987)

(4,842)

(5,495)

(4,756)

(4,868)

(4,852)

 

Share of post tax results of associates & JVs

18 

19 

17 

16 

18 

15 

 

Gains/(losses) on acquisitions and disposals

(67)

76 

33 

100 

 

Profit before tax

2,422 

989 

1,655 

1,791 

327 

2,127 

1,820 

 

 

Adjusted profit before tax

1,337 

1,674 

2,004 

1,228 

1,273 

1,141 

1,822 

 

 

Basic earnings per share

9.7p

4.0p

8.5p

9.1p

0.4p

11.6p

9.3p

 

Cost: income ratio

47%

75%

65%

64%

76%

57%

60%

 

Cost: net operating income ratio

66%

85%

75%

76%

94%

70%

74%

 

Adjusted cost: income ratio1 

67%

66%

62%

68%

66%

64%

59%

 

Adjusted cost: net operating income ratio1 

78%

75%

71%

82%

79%

81%

73%

 

 

Adjusted

Statutory

Nine Months Ended

Nine Months Ended

Profit Before Tax by Business

30.09.11

30.09.10

30.09.11

30.09.10

UK RBB

1,198 

634

798 

734

Europe RBB

(109)

(63)

(109)

(34)

Africa RBB

622 

550

624 

554

Barclaycard

902 

561

302 

561

Retail and Business Banking

2,613 

1,682

1,615 

1,815 

Barclays Capital

2,698 

3,314

5,669 

3,218

Barclays Corporate

106 

(414)

42 

(414)

Corporate and Investment Banking

2,804 

2,900

5,711 

2,804 

Barclays Wealth

153 

122

153 

122

Investment Management

80 

55

(1,778)

55

Head Office Functions and Other Operations

(635)

(523)

(635)

(522)

Group profit before tax

5,015 

4,236

5,066 

4,274 

  

  

30.09.11

30.09.10

Income by Geographic Segment2 

£m

%  

£m

%  

UK

9,476 

42

9,395 

41

Europe

3,566 

16

3,443 

15

Americas

4,637 

21

5,639 

24

Africa and the Middle East

3,784 

17

3,614 

16

Asia

779 

4

877 

4

Total income net of insurance claims (excluding own credit)

22,242 

100

22,968 

100 

 

 

 

 

 

 

 

 

 

1 Adjusted profit before tax and adjusted performance metrics have been presented to provide a more consistent basis for comparing business performance between periods. These measures exclude: the impact of own credit; the impairment of the investment in BlackRock, Inc.; the provision for PPI redress; and gains and losses on acquisitions and disposals of subsidiaries, associates, joint ventures and strategic investments

2 Total income net of insurance claims (excluding own credit) based on counterparty location

Capital

- Core Tier 1 remained strong at 11.0% (30 June 2011: 11.0%), with risk weighted assets flat at £390bn (30 June 2011: £395bn). Adjusted gross leverage was 21x (30 June 2011: 20x)

- Eurozone country exposures continue to be managed closely and valued appropriately. The Group's sovereign exposure to Spain, Italy, Portugal, Ireland and Greece reduced in Q3 by 31% to £8.0bn

- £6bn of term funding raised in Q3 2011, making £24bn in 2011 year to date. This compares to full year 2011 term funding maturities of £25bn

- Robust liquidity position with a liquidity pool of £166bn (30 June 2011: £145bn), which represent over a year of wholesale maturities, of which £152bn is FSA-eligible

- Net asset value per share increased 16p to 439p during Q3 and net tangible asset value per share increased 19p to 372p

Returns

- Adjusted return on average shareholders' equity improved to 8.1% (2010: 6.5%) and adjusted return on average tangible shareholders' equity improved to 9.7% (2010: 7.9%). These returns on a statutory basis improved to 6.9% (2010: 6.7%) and 8.3% (2010: 8.1%) respectively

- Adjusted profit before tax of £5,015m up 18%. Statutory profit before tax of £5,066m up 19%

- Impairment charges and other credit provisions of £2,851m down 34%, resulting in a year-to-date annualised loan loss rate of 74bps (2010: 110bps)

- BlackRock, Inc. investment assessed as impaired for accounting purposes, resulting in recycling through the income statement of the £1,800m cumulative reduction in fair value, which was already recognised in equity and deducted for regulatory capital purposes

- Operating expenses excluding PPI provision, flat at £14,488m

- Third interim dividend of 1.0p per share, making 3.0p for the year to date

Income Growth

- Income excluding own credit down 3% to £22,242m. Including own credit, income was up 10% to £25,213m. Own credit gain of £2,882m in the third quarter driven by widening credit spreads on Barclays Capital structured notes, which are held at fair value

- Net operating income up 4% to £19,391m excluding own credit and impairment of investment in BlackRock, Inc. Statutory net operating income up 11% to £20,562m

- Increased contribution from RBB, Barclays Corporate and Barclays Wealth, which together generated a 6% increase in income. Net interest margin was up 9bps to 2.10%, reflecting improvements in the underlying margin and hedging activities

- Increase in net benefit from Group hedging activities of £559m (full year 2010: £665m)

Citizenship

- Increased 2011 gross new UK lending to businesses of £33bn, including £11bn to SMEs, with the Group on track to exceed Project Merlin targets for 2011

- Extended access to basic financial services in 11 countries across Africa, Asia and South America, reaching more than 130,000 new people through our Banking On Change programme including community-led savings and loans groups

- Reached over 175,000 disadvantaged people through our Building Young Futures partnership with UNICEF, including provision of business or vocational skills training to over 112,000

 

 

 

 

Business Performance

 

 

Nine Months Ended

Nine Months Ended

UK RBB

30.09.11

30.09.10

£m

£m

% Change

Total income net of insurance claims

3,527 

3,332 

Impairment charges and other credit provisions

(380)

(649)

(41)

Net operating income

3,147 

2,683 

17 

Operating expenses (excluding provision for PPI redress)

(1,950)

(2,047)

(5)

Provision for PPI redress

(400)

nm

Total operating expenses

(2,350)

(2,047)

15 

Share of post tax results of associates & JVs

(2)

nm

Gains on acquisitions and disposals

100 

nm

Profit before tax

798 

734 

Adjusted profit before tax

1,198 

634 

89 

 

- Increase in income of 6% reflecting strong growth in mortgages and personal savings partially offset by a reduction in income following closure of the branch-based financial planning business

- Impairment charges reduced by 41% due to significant improvement in unsecured lending

- Operating expenses down 5% excluding the provision for PPI redress

 

Nine Months Ended

Nine Months Ended

Europe RBB

30.09.11

30.09.10

£m

£m

% Change

Total income net of insurance claims

979 

901 

Impairment charges and other credit provisions

(178)

(225)

(21)

Net operating income

801 

676 

18 

Operating expenses

(920)

(750)

23 

Share of post tax results of associates & JVs

10 

11 

(9)

Gains on acquisitions and disposals

29 

(100)

Loss before tax

(109)

(34)

nm

Adjusted loss before tax

(109)

(63)

73 

 

- Adjusted loss of £109m (2010: loss of £63m) including £129m (2010: £nil) of restructuring charges principally related to operations in Spain

- Strong growth in income of 9% driven by an improved liability margin and the appreciation of the Euro against Sterling

- Impairment charges improved by 21% reflecting focused risk management and stable arrears rates

- Operating expenses increased by 23% reflecting restructuring charges, Italian and Portuguese branch expansion during 2010 and the appreciation of the Euro against Sterling

 

Nine Months Ended

Nine Months Ended

Africa RBB

30.09.11

30.09.10

£m

£m

% Change

Total income net of insurance claims

2,861 

2,717 

Impairment charges and other credit provisions

(377)

(425)

(11)

Net operating income

2,484 

2,292 

Operating expenses

(1,865)

(1,740)

Share of post tax results of associates & JVs

(2)

nm

Gains on acquisitions and disposals

(50)

Profit before tax

624 

554 

13 

Adjusted profit before tax

622 

550 

13 

 

- Profit before tax increased 13%, or 25% excluding a one off pension credit of £54m in 2010

- Income showed growth of 5% driven by improved performance in South Africa

- Impairment charges improved by 11% reflecting more stable economic conditions with improved retail collections and commercial recoveries

- Operating expenses increased 7% primarily reflecting inflationary pressures in South Africa and non recurrence of a pension credit in 2010

 

Nine Months Ended

Nine Months Ended

Barclaycard

30.09.11

30.09.10

£m

£m

% Change

Total income net of insurance claims

3,112 

2,988 

Impairment charges and other credit provisions

(988)

(1,295)

(24)

Net operating income

2,124 

1,693 

25 

Operating expenses (excluding provision for PPI redress)

(1,248)

(1,150)

Provision for PPI redress

(600)

nm

Total operating expenses

(1,848)

(1,150)

61 

Share of post tax results of associates & JVs

26 

18 

44 

Profit before tax

302 

561 

(46)

Adjusted profit before tax

902 

561 

61 

 

- Income was 4% ahead of prior year with growth in balances driven by UK Cards, partly offset by customer balance repayments in the US and appreciation of Sterling against the US Dollar

- Impairment charges reduced by 24% reflecting focused risk management and customer balance repayments. The 30 day delinquency rate continued to improve in the UK and the US. This led to a 163bps increase in risk adjusted margin

- Operating expenses were in line with prior year, after excluding the provision for PPI redress, goodwill impairment and portfolio acquisitions

 

Nine Months Ended

Nine Months Ended

Barclays Capital

30.09.11

30.09.10

£m

£m

% Change

Fixed Income, Currency and Commodities

5,354 

6,656 

(20)

Equities and Prime Services

1,446 

1,415 

Investment Banking

1,521 

1,518 

Principal Investments

196 

124 

58 

Total income net of insurance claims (excluding own credit)

8,517 

9,713 

(12)

Own credit

2,971 

(96)

nm

Total income net of insurance claims

11,488 

9,617 

19 

Impairment charges and other credit provisions

(3)

(321)

(99)

Net operating income

11,485 

9,296 

24 

Operating expenses

(5,831)

(6,094)

(4)

Share of post tax results of associates & JVs

15 

16 

(6)

Profit before tax

5,669 

3,218 

76 

Adjusted profit before tax

2,698 

3,314 

(19)

 

- Total income excluding own credit was down 12% on 2010

- Fixed Income, Currency and Commodities (FICC) income declined 20%, reflecting lower contributions from the Credit, Commodities and Emerging Markets businesses, partially offset by an improved performance in Foreign Exchange which benefited from strong client volumes, and Group hedging activities

- Equities and Prime Services income increased 2% reflecting improved performance in equity financing

- Investment Banking income was flat with improved performance in equity underwriting and M&A advisory offset by a decrease in debt underwriting

- Total income excluding own credit in the third quarter of 2011 was down 22% on the second quarter of 2011 reflecting reduced income of 16% in FICC, 40% in Equities and Prime Services and 25% in Investment Banking

- Net operating income excluding own credit reduced 9%, having benefited from a significant reduction inimpairment charges to £3m (2010: £321m) principally reflecting charges relating to leveraged finance exposures, offset by a release of £223m against the loan to Protium Finance LLP (Protium) in the first half of 2011

- Operating expenses declined 4% reflecting the reduction in net operating income excluding own credit. Excluding the impact of own credit, the cost to net operating income ratio was 68% and the compensation to income ratio was 46%

 

Nine Months Ended

Nine Months Ended

Barclays Corporate

30.09.11

30.09.10

£m

£m

% Change

Total income net of insurance claims

2,247 

2,167 

Impairment charges and other credit provisions

(896)

(1,354)

(34)

Net operating income

1,351 

813 

66 

Operating expenses

(1,246)

(1,227)

Share of post tax results of associates & JVs

nm

Loss on disposal

(64)

nm

Profit/(loss) before tax

42 

(414)

nm

Adjusted profit/(loss) before tax

106 

(414)

nm

 

Adjusted profit before tax by geographic segment

UK

592 

563 

Europe

(434)

(700)

(38)

Rest of the World

(52)

(277)

(81)

Barclays Corporate

106 

(414)

nm

- UK profit before tax up 5% largely reflecting solid income growth, including benefit from Group hedging activity, and a reduction in impairment, partially offset by an increase in costs mainly due to the non-recurrence of a prior year pension credit

- Europe loss before tax improved 38% principally due to lower impairment charges in Spain of £415m (2010: £751m)

- Rest of the World adjusted loss before tax improved 81% principally due to the non-recurrence of 2010 restructuring charges and subsequent benefits. A significant improvement in impairment charges reflected management action to reduce the risk profile of portfolios

Nine Months Ended

Nine Months Ended

Barclays Wealth

30.09.11

30.09.10

£m

£m

% Change

Total income net of insurance claims

1,295 

1,143 

13 

Impairment charges and other credit provisions

(31)

(35)

(11)

Net operating income

1,264 

1,108 

14 

Operating expenses

(1,109)

(986)

12 

Share of post tax results of associates & JVs

(2)

nm

Profit before tax

153 

122 

25 

Adjusted profit before tax

153 

122 

25 

 

- Strong income growth of 13% was driven by the High Net Worth businesses

- Operating expenses increased 12% due to uplift in investment spend and related restructuring costs as well as staff and infrastructure costs from growth in the High Net Worth businesses

 

Nine Months Ended

Nine Months Ended

Investment Management

30.09.11

30.09.10

£m

£m

% Change

Total income net of insurance claims

31 

58 

(47)

Impairment of investment in BlackRock, Inc.

(1,800)

nm

Net operating income

(1,769)

58 

nm

Operating expenses

(9)

(3)

nm

(Loss)/profit before tax

(1,778)

55 

nm

Adjusted profit before tax

80 

55 

45 

 

- Adjusted profit before tax of £80m (2010: £55m), principally reflected dividend income from the Group's available for sale holding in BlackRock, Inc. which represents a 19.7% interest

- The loss before tax of £1,778m (2010: profit of £55m) resulted from an assessment for accounting purposes that there was objective evidence that the Group's investment in BlackRock, Inc. was impaired. For regulatory capital purposes, the reduction in fair value of £1,800m has already been recognised in the Group's Core Tier 1 capital

- The impairment reflects the recycling through the income statement of the cumulative reduction in market value previously recognised in equity, since the Group's acquisition of its holding in BlackRock, Inc. as part of the sale of Barclays Global Investors on 1 December 2009. The fair value of the holding as at 30 September 2011 was £3.6bn

 

Nine Months Ended

Nine Months Ended

Head Office and Other Operations

30.09.11

30.09.10

£m

£m

% Change

Loss before tax

(635)

(522)

22 

Adjusted loss before tax

(635)

(523)

21 

 

- Loss before tax increased 22% largely due to a currency translation gain of £270m in 2010 relating to the repatriation of capital from overseas operations, partially offset by the non-recurrence of 2010 costs of £194m relating to compliance with US economic sanctions

- In accordance with International Financial Reporting Standards, the impact of the UK bank levy, for which legislation was enacted in July 2011, has not been reflected in these results. The total cost for 2011 is expected to be in the range of £330m-£380m

 

 

Credit Impairment

- Credit impairment charges and other provisions fell 34% to £2,851m

- Charges were lower across all RBB businesses, most notably in Barclaycard and unsecured personal loans and overdrafts in UK RBB, mainly due to lower delinquency rates, reflecting a general improvement in asset quality, the low interest rate environment and broadly flat unemployment rates in the UK and US in the year to date

- The £3m charge in Barclays Capital resulted principally from charges relating to leveraged finance exposures, offset by a release of £223m against the loan to Protium in the first half of 2011

- Charges were lower in Barclays Corporate, notably in Spain and UK, although charges were higher in Portugal where credit conditions remained weak

- The annualised loan loss rate reduced to 74bps (2010: 110bps) and is unchanged from 30 June 2011, as the higher impairment charge on loans and advances in the third quarter was offset by a 2% increase in loans and advances

- Delinquency trends were stable or improving in the majority of retail portfolios with the exception of certain European portfolios, which have experienced some deterioration in the past few months

- The Group's credit risk loans (CRL) coverage ratio remained broadly stable in the third quarter as both CRL balances and impairment allowances fell modestly

Liquidity and Funding

- Barclays liquidity pool increased to £166bn as at 30 September 2011 (30 June 2011: £145bn) and moved within a month end range of £145bn to £166bn during Q3. The increase was largely as a result of increased deposit-taking through the third quarter. The pool represents more than a year of wholesale maturities and includes £152bn FSA eligible assets1

 

Liquidity Pool

Cash and Deposits

With Central Banks

Government

Guaranteed Bonds

Government and

Supranational Bonds

Other Available

Liquidity

Total

£bn

£bn

£bn

£bn

£bn

As at 30.09.112

100 

53 

12 

166 

As at 30.06.11

85 

48 

11 

145 

 

- As at 30 September 2011, the Group has £146bn of wholesale debt maturing in less than one year. This includes £38bn of term funding, of which £16bn matures during Q4 2011

- Term funding raised over the first nine months of 2011 was £24bn, compared to full year term funding maturities of £25bn. In the third quarter, the Group raised £3bn term debt via Barclays Capital's private placement MTN programmes and £3bn in publicly issued covered bonds and credit card securitisations

- Funding continues to be raised at attractive rates and, as a result of the current funding position, the Group can be selective in accessing public term funding markets

- Retail and Business Banking (excluding Absa), Barclays Corporate and Barclays Wealth activities are largely funded with customer deposits. The funding gap for these businesses is met using asset backed securities and covered bonds, secured primarily over customer loans and advances such as residential mortgages and credit card receivables. The loan to deposit ratio for these businesses is 109% and the ratio of loans to deposits and secured funding is 99%

- Barclays Capital is primarily funded through wholesale markets. The Group maintains access to a variety of sources of wholesale funds, including unsecured money markets, repo markets and term investors, across a variety of distribution channels and geographies. The Group wholesale funding profile, including tenor and concentration risks, is managed under the Group Liquidity Risk Framework, which is subject to FSA supervision, to ensure sufficient liquidity is held to cover potential cash outflows in a stressed environment

 

 

 

 

 

 

 

1 High quality unencumbered assets that meet the requirements of the FSA liquidity regime, primarily comprising deposits with central banks and Government bonds

2  Over 95% of central bank deposits are placed with the Bank of England, US Federal Reserve, European Central Bank, Bank of Japan and Swiss National Bank. 80% of Government and supranational bonds are comprised of UK, US, Japanese, French, German and Dutch securities

 

Group Exposures to Selected Eurozone Countries

- The Group continues to closely monitor its exposure to Eurozone countries. Detailed information on the Group's balance sheet positions in Spain, Italy, Portugal, Ireland and Greece as at 30 September 2011 is set out on pages 14-16

- During Q3 the Group's sovereign exposure to these countries reduced by 31% to £8.0bn

- Spanish sovereign exposure reduced 43% to £2.7bn due to the sale of available for sale government bonds held for interest rate hedging purposes that have been replaced by interest rate swaps with alternative counterparties

- Italian sovereign exposures reduced 24% to £4.1bn as government bond positions were closed out

- Portuguese sovereign exposure reduced 17% to £805m with a reduction in client activity

- Exposure to Ireland remained broadly flat in Q3, principally comprising exposures to financial institutions of £4.4bn (30 June 2011: £4.5bn), including £1.3bn of trading assets and £1.1bn of loans to entities domiciled in Ireland whose principal business and exposures are outside of Ireland. Exposures to domestic Irish banks remained below £250m

- Exposure to Greece remained minimal, including sovereign exposures of £23m

Dividends

- It is our policy to declare and pay dividends on a quarterly basis. We will pay a third interim cash dividend for 2011 of 1p per share on 9 December 2011, giving a declared dividend for the year to date of 3p per share

Outlook

- Capital markets remained difficult in October but have shown some improvement since the announcement by Eurozone leaders last week. Our retail, corporate and wealth businesses have performed broadly in line with their underlying run rates for the first nine months of the year

Other Information

Results Timetable

Date

Ex-dividend date

9 November 2011

Dividend Record date

11 November 2011

Dividend Payment date

9 December 2011

2011 Full Year Results Announcement

15 February 2012

Q1 2012 Interim Management Statement

26 April 2012

 

For Further Information Please Contact

 

Investor Relations

Media Relations

Charlie Rozes +44 (0) 20 7116 7599

Giles Croot +44 (0) 20 7116 6132

More information on Barclays can be found on our website: www.barclays.com

 

Notes

- Unless otherwise stated, the income statement analyses compare the nine months to 30 September 2011to the corresponding period in 2010. Balance sheet comparisons, unless otherwise stated, relate to the corresponding position as at 30 June 2011

- Adjusted profit before tax and adjusted performance metrics have been presented to provide a more consistent basis for comparing business performance between periods. These measures exclude: the impact of own credit; the impairment of the investment in BlackRock, Inc.; the provision for PPI redress; and gains and losses on acquisitions and disposals of subsidiaries, associates, joint ventures and strategic investments

- The financial information on which this Interim Management Statement is based, and other data set out in the appendices to this statement, are unaudited and have been prepared in accordance with Barclays previously stated accounting policies described in the 2010 Annual Report. A glossary of terms is also set out in the 2010 Annual Report

- For qualifying US and Canadian resident ADR holders, the interim dividend of 1p per ordinary share becomes 4p per ADS (representing four shares). The ADR depositary will mail the interim dividend on 9 December 2011 to ADR holders on the record on 11 November 2011

Forward-looking Statements

This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to certain of the Group's plans and its current goals and expectations relating to its future financial condition and performance. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking statements. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as "may", "will", "seek", "continue", "aim", "anticipate", "target", "expect", "estimate", "intend", "plan", "goal", "believe" or other words of similar meaning. Examples of forward-looking statements include, among others, statements regarding the Group's future financial position, income growth, assets, impairment charges, business strategy, capital ratios, leverage, payment of dividends, projected levels of growth in the banking and financial markets, projected costs, estimates of capital expenditures, and plans and objectives for future operations and other statements that are not historical fact. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances, including, but not limited to, UK domestic, Eurozone and global economic and business conditions, the effects of continued volatility in credit markets, market related risks such as changes in interest rates and exchange rates, effects of changes in valuation of credit market exposures, changes in valuation of issued notes, the policies and actions of governmental and regulatory authorities (including requirements regarding capital and Group structures), changes in legislation, the further development of standards and interpretations under IFRS applicable to past, current and future periods, evolving practices with regard to the interpretation and application of standards under IFRS, the outcome of pending and future litigation, the success of future acquisitions and other strategic transactions and the impact of competition - a number of such factors being beyond the Group's control. As a result, the Group's actual future results may differ materially from the plans, goals, and expectations set forth in the Group's forward-looking statements.

 

Any forward-looking statements made herein speak only as of the date they are made. Except as required by the UK Financial Services Authority, the London Stock Exchange plc or applicable law, Barclays expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this announcement to reflect any change in Barclays expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. The reader should, however, consult any additional disclosures that Barclays has made or may make in documents it has filed or may file with the LSE and/or the US Securities and Exchange Commission.

 

 

 

 

Q311 IMS Appendix I - Quarterly Results Summary

UK RBB

Q311

Q211

Q111

Q410

Q310

Q210

Q110

£m

£m

£m

£m

£m

£m

£m

Total income net of insurance claims

1,273 

1,170 

1,084 

1,186 

1,161 

1,087 

1,084 

Impairment charges and other credit provisions

(105)

(131)

(144)

(170)

(202)

(222)

(225)

Net operating income

1,168 

1,039 

940 

1,016 

959 

865 

859 

Operating expenses (excluding provision for PPI redress)

(675)

(622)

(653)

(762)

(725)

(628)

(694)

Provision for PPI redress1 

(400)

Total operating expenses

(675)

(1,022)

(653)

(762)

(725)

(628)

(694)

Share of post tax results of associates & JVs

(1)

(4)

Gains on acquisitions and disposals1 

29 

71 

Profit before tax

494 

16 

288 

255 

230 

266 

238 

Adjusted profit before tax

494 

416 

288 

255 

230 

237 

167 

 

Europe RBB

 

Total income net of insurance claims

375 

309 

295 

263 

299 

297 

305 

Impairment charges and other credit provisions

(62)

(47)

(69)

(89)

(92)

(62)

(71)

Net operating income

313 

262 

226 

174 

207 

235 

234 

Operating expenses

(263)

(368)

(289)

(283)

(255)

(246)

(249)

Share of post tax results of associates & JVs

Gains on acquisitions and disposals1 

29 

Profit/(loss) before tax

52 

(102)

(59)

(105)

(44)

(7)

17 

Adjusted profit/(loss) before tax

52 

(102)

(59)

(105)

(44)

(7)

(12)

 

Africa RBB

 

Total income net of insurance claims

994 

955 

912 

983 

935 

900 

882 

Impairment charges and other credit provisions

(109)

(126)

(142)

(137)

(95)

(164)

(166)

Net operating income

885 

829 

770 

846 

840 

736 

716 

Operating expenses

(642)

(618)

(605)

(678)

(671)

(549)

(520)

Share of post tax results of associates & JVs

(3)

Gains on acquisitions and disposals1 

77 

Profit before tax

245 

212 

167 

250 

166 

191 

197 

Adjusted profit before tax

243 

212 

167 

173 

166 

187 

197 

 

Barclaycard

 

Total income net of insurance claims

1,140 

1,012 

960 

1,036 

1,030 

981 

977 

Impairment charges and other credit provisions

(340)

(344)

(304)

(393)

(405)

(425)

(465)

Net operating income

800 

668 

656 

643 

625 

556 

512 

Operating expenses (excluding provision for PPI redress)

(430)

(447)

(371)

(420)

(386)

(364)

(400)

Provision for PPI redress1 

(600)

Total operating expenses

(430)

(1,047)

(371)

(420)

(386)

(364)

(400)

Share of post tax results of associates & JVs

11 

Profit/(loss) before tax

378 

(372)

296 

230 

244 

199 

118 

Adjusted profit before tax

378 

228 

296 

230 

244 

199 

118 

 

 

  

1 Excluded for adjusted profit before tax and adjusted performance metrics

 

 

Barclays Capital

Q311

Q211

Q111

Q410

Q310

Q210

Q110

£m

£m

£m

£m

£m

£m

£m

Fixed Income, Currency and Commodities

1,438 

1,715 

2,201 

2,031 

1,773 

2,138 

2,745 

Equities and Prime Services

338 

563 

545 

625 

359 

563 

493 

Investment Banking

389 

520 

612 

725 

501 

461 

556 

Principal Investments

89 

99 

115 

19 

101 

Total income (excluding own credit)

2,254 

2,897 

3,366 

3,496 

2,652 

3,166 

3,895 

Own credit gain/(charge)1 

2,882 

440 

(351)

487 

(947)

953 

(102)

Total income

5,136 

3,337 

3,015 

3,983 

1,705 

4,119 

3,793 

Impairment charges and other credit provisions

(114)

80 

31 

(222)

(12)

(41)

(268)

Net operating income

5,022 

3,417 

3,046 

3,761 

1,693 

4,078 

3,525 

Operating expenses

(1,758)

(2,006)

(2,067)

(2,201)

(1,881)

(2,154)

(2,059)

Share of post tax results of associates and JVs

Profit/(loss) before tax

3,270 

1,417 

982 

1,562 

(182)

1,931 

1,469 

Adjusted profit before tax

388 

977 

1,333 

1,075 

765 

978 

1,571 

 

Barclays Corporate

 

Total income net of insurance claims

776 

768 

703 

807 

766 

683 

718 

Impairment charges and other credit provisions

(282)

(327)

(287)

(342)

(405)

(642)

(307)

Net operating income

494 

441 

416 

465 

361 

41 

411 

Operating expenses

(407)

(427)

(412)

(680)

(398)

(343)

(486)

Share of post tax results of associates & JVs

(3)

(2)

Losses on disposal1

(64)

Profit/(loss) before tax

89 

(48)

(217)

(37)

(302)

(75)

Adjusted profit/(loss) before tax

89 

16 

(217)

(37)

(302)

(75)

 

Barclays Wealth

 

Total income net of insurance claims

447 

426 

422 

417 

386 

387 

370 

Impairment charges and other credit provisions

(12)

(9)

(10)

(13)

(8)

(17)

(10)

Net operating income

435 

417 

412 

404 

378 

370 

360 

Operating expenses

(369)

(375)

(365)

(363)

(351)

(320)

(315)

Share of post tax results of associates & JVs

(1)

(1)

Profit before tax

65 

42 

46 

41 

27 

50 

45 

Adjusted profit before tax

65 

42 

46 

41 

27 

50 

45 

 

Investment Management

 

Total income net of insurance claims

32 

(25)

24 

20 

24 

29 

Impairment of investment in BlackRock, Inc.1 

(1,800)

Net operating income

(1,768)

(25)

24 

20 

24 

29 

Operating expenses

(3)

(6)

(8)

(3)

(Loss)/profit before tax

(1,771)

(31)

24 

12 

24 

29 

Adjusted profit before tax

29 

27 

24 

12 

24 

29 

 

Head Office Functions and Other Operations

 

Loss before tax

(400)

(145)

(90)

(237)

(101)

(203)

(218)

Adjusted loss before tax

(401)

(142)

(92)

(236)

(102)

(203)

(218)

 

 

1 Excluded for adjusted profit before tax and adjusted performance metrics

2 Q2 2011 includes a £58m loss on disposal of a portion of the Group's strategic investment in BlackRock, Inc. recycled through investment income that is excluded for adjusted profit before tax and adjusted performance metrics

 

 

Q311 IMS Appendix II - Risk Management

Analysis of Loans and Advances to Customers and Banks

As at 30.09.11

Gross

L&A

Impairment Allowance

L&A Net of Impairment

Impairment Charges1 

Loan Loss Rates2 

£m

£m

£m

£m

bps

Wholesale - customers

223,780 

5,261 

218,519 

1,020

61

Wholesale - banks

58,899 

45 

58,854 

(7)

(2)

Total wholesale

282,679 

5,306 

277,373 

1,013

48

Total retail

238,823 

5,997 

232,826 

1,858

104

Loans and advances at amortised cost

521,502 

11,303 

510,199 

2,871

74

Loans and advances held at fair value

24,147 

na

24,147 

Total loans and advances

545,649 

11,303 

534,346 

As at 30.06.11

  

  

Wholesale - customers

212,523 

5,132 

207,391 

621

59

Wholesale - banks

58,799 

48 

58,751 

(4)

(1)

Total wholesale

271,322 

5,180 

266,142 

617

46

Total retail

241,033 

6,441 

234,592 

1,257

105

Loans and advances at amortised cost

512,355 

11,621 

500,734 

1,874

74

Loans and advances held at fair value

23,779 

na

23,779 

Total loans and advances

536,134 

11,621 

524,513 

 

 

1 The impairment charge provided above relates to the nine months ended 30 September 2011 and six months ended 30 June 2011

2 Loan loss rates have been calculated on an annualised basis

Q311 IMS Appendix III - Group Exposures to Selected Eurozone Countries

Group Exposures to Selected Eurozone Countries

- The following tables are prepared on the same basis as the 2011 Interim Results Announcement and present the maximum direct balance sheet exposure to credit risk by country, with the totals reflecting allowance for impairment, netting and cash collateral held where appropriate

- Trading and derivatives balances relate to investment banking activities, principally as market maker for government bond positions. Positions are held at fair value, with daily movements taken through profit and loss

- Available for sale assets are principally investments in government bonds and other debt securities held for the purposes of interest rate hedging and liquidity for local banking activities. Balances are reported on a fair value basis, with movements in fair value going through equity

- Loans and advances held at amortised cost, comprising: retail lending portfolios, predominantly mortgages secured on residential property; and corporate lending portfolios largely reflecting established corporate banking businesses in Spain, Italy and Portugal and investment banking services provided to multinational and large national corporate clients

- Sovereign exposures reflect direct exposures to central and local government, the majority of which are used for hedging interest rate risk relating to local activities. These positions are being actively replaced by non-government instruments such as interest rate swaps. The remaining portion is actively managed reflecting our role as leading primary dealer, market maker and liquidity provider to our clients

- Financial institution and corporate exposuresreflect the country of operations of the immediate counterparty (including foreign subsidiaries and without reference to cross-border guarantees)

- Retail exposures reflect the country of residence of retail customers

- The Group enters into credit mitigation arrangements for risk management purposes (principally credit default swaps and total return swaps) for which the reference asset is government debt. These have the net effect of reducing the Group's exposure to these Eurozone countries. Only credit mitigation arrangements with counterparties in these countries are reflected in the analysis below. Credit mitigation arrangements with counterparties outside of these countries, for which the reference asset is Eurozone government debt, are not included in the analysis below

 

Spain

Trading Portfolio

Derivatives

Designated as Fair Value Through P&L

Fair Value through Profit and Loss

 

Trading Portfolio Assets

Trading Portfolio Liabilities

Net

 Trading Portfolio

Gross Assets

Gross Liabilities

Cash Collateral

Net Derivatives

Total

as at

30.09.11

Total

as at

30.06.11

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

Sovereign

 1,036 

 (850)

186 

 101 

 (101)

 - 

 - 

 - 

 186 

 48 

Financial institutions

 428 

 (247)

181 

 9,020 

 (8,994)

 (26)

-

 - 

 181 

 343 

Corporate

 118 

 (99)

19 

 597 

 (289)

 (2)

 306 

 86 

 411 

 340 

Fair Value through Equity

Available for Sale Assets as at 30.09.11

Total

as at

Cost

AFS Reserve

Total

30.06.11

£m

£m

£m

£m

Sovereign

 2,454 

 12 

 2,466 

 4,713 

Financial institutions

 593 

 (17)

 576 

 558 

Corporate

 16 

 (1)

 15 

 25 

Held at Amortised Cost

Loans and Advances as at 30.09.11

Total

as at

Gross

Impairment Allowances

Total

30.06.11

£m

£m

£m

£m

Sovereign

 65 

 (1)

 64 

 39 

Financial institutions

 322 

 (8)

 314 

 370 

Residential mortgages

 15,305 

 (95)

 15,210 

 16,503 

Corporate

 6,434 

 (1,348)

 5,086 

 5,281 

Other retail lending

 3,405 

 (162)

 3,243 

 3,170 

 

 

 

 

Italy

Trading Portfolio

Derivatives

Designated as Fair Value Through P&L

Fair Value through Profit and Loss

 

Trading Portfolio Assets

Trading Portfolio Liabilities

Net

 Trading Portfolio

Gross Assets

Gross Liabilities

Cash Collateral

Net Derivatives

Total

as at

30.09.11

Total

as at

30.06.11

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

Sovereign

 3,606 

 (2,621)

985 

 1,373 

 (605)

 (100)

668 

 1 

1,654 

 2,757 

Financial institutions

 491 

 (81)

410 

 7,153 

 (5,724)

 (1,147)

282 

 - 

692 

 673 

Corporate

 121 

 (79)

42 

 485 

 (306)

 (93)

86 

 - 

128 

 112 

Fair Value through Equity

Available for Sale Assets as at 30.09.11

Total

as at

Cost

AFS Reserve

Total

30.06.11

£m

£m

£m

£m

Sovereign

 2,399 

 64 

 2,463 

 2,686 

Financial institutions

 194 

 2 

 196 

 153 

Corporate

 26 

 (1)

 25 

 17 

Held at Amortised Cost

Loans and Advances as at 30.09.11

Total

as at

Gross

Impairment Allowances

Total

30.06.11

£m

£m

£m

£m

Sovereign

 17 

 - 

 17 

 - 

Financial institutions

 73 

 (12)

 61 

 14 

Residential mortgages

 15,561 

 (84)

 15,477 

 15,486 

Corporate

 2,675 

 (162)

 2,513 

 2,714 

Other retail lending

 2,608 

 (178)

 2,430 

 2,473 

 

Portugal

Trading Portfolio

Derivatives

Designated as Fair Value Through P&L

Fair Value through Profit and Loss

 

Trading Portfolio Assets

Trading Portfolio Liabilities

Net

 Trading Portfolio

Gross Assets

Gross Liabilities

Cash Collateral

Net Derivatives

Total

as at

30.09.11

Total

as at

30.06.11

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

Sovereign

 144 

 (107)

 37 

 429 

 (429)

 - 

 - 

 3 

 40 

 152 

Financial institutions

 49 

 (15)

 34 

 333 

 (333)

 - 

 - 

 - 

 34 

 30 

Corporate

 1 

 (1)

 - 

 215 

 (84)

 - 

 131 

 - 

 131 

 110 

Fair Value through Equity

Available for Sale Assets as at 30.09.11

Total

as at

Cost

AFS Reserve

Total

30.06.11

£m

£m

£m

£m

Sovereign

 893 

 (155)

 738 

 792 

Financial institutions

 2 

 - 

 2 

 3 

 

Corporate

 879 

 (6)

 873 

 1,033 

Held at Amortised Cost

Loans and Advances as at 30.09.11

Total

as at

Gross

Impairment Allowances

Total

30.06.11

£m

£m

£m

£m

Sovereign

 27 

 - 

 27 

 26 

Financial institutions

 18 

 - 

 18 

 45 

Residential mortgages

 3,704 

 (13)

 3,691 

 3,828 

Corporate

 2,747 

 (175)

 2,572 

 2,721 

Other retail lending

 2,264 

 (200)

 2,064 

 2,143 

 

 

Ireland

Trading Portfolio

Derivatives

Designated as Fair Value Through P&L

Fair Value through Profit and Loss

 

Trading Portfolio Assets

Trading Portfolio Liabilities

Net

 Trading Portfolio

Gross Assets

Gross Liabilities

Cash Collateral

Net Derivatives

Total

as at

30.09.11

Total

as at

30.06.11

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

Sovereign

 133 

 (133)

 - 

 491 

 (108)

 (372)

 11 

 1 

 12 

 148 

Financial institutions

 1,788 

 (52)

 1,736 

 5,979 

 (5,366)

 (613)

 - 

 49 

 1,785 

 1,591 

Corporate

 78 

 (17)

 61 

 643 

 (643)

 - 

 - 

 9 

 70 

 243 

Fair Value through Equity

Available for Sale Assets as at 30.09.11

Total

as at

Cost

AFS Reserve

Total

30.06.11

£m

£m

£m

£m

Sovereign

 214 

 7 

 221 

 183 

Financial institutions

 244 

 14 

 258 

 253 

Corporate

 5 

 - 

 5 

 15 

Held at Amortised Cost

Loans and Advances as at 30.09.11

Total

as at

Gross

Impairment Allowances

Total

30.06.11

£m

£m

£m

£m

Sovereign

 120 

 - 

120 

Financial institutions

 2,471 

 (148)

 2,323 

 2,622 

Residential mortgages

 114 

 (1)

 113 

 87 

Corporate

 991 

(21)

 970 

 1,056 

Other retail lending

 293 

 (3)

 290 

 296 

 

Greece

Trading Portfolio

Derivatives

Designated as Fair Value Through P&L

Fair Value through Profit and Loss

 

Trading Portfolio Assets

Trading Portfolio Liabilities

Net

 Trading Portfolio

Gross Assets

Gross Liabilities

Cash Collateral

Net Derivatives

Total

as at

30.09.11

Total

as at

30.06.11

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

Sovereign

 14 

 (2)

 12 

 7 

 (3)

 (3)

 1 

 - 

 13 

 55 

Financial institutions

 2 

 - 

 2 

 1,097 

 (266)

 (731)

 100 

 - 

 102 

 93 

Corporate

 4 

 - 

 4 

 1 

 - 

 - 

 1 

 - 

 5 

 18 

Fair Value through Equity

Available for Sale Assets as at 30.09.11

Total

as at

Cost

AFS Reserve

Total

30.06.11

£m

£m

£m

£m

Sovereign

 10 

-

 10 

 14 

Held at Amortised Cost

Loans and Advances as at 30.09.11

Total

as at

Gross

Impairment Allowances

Total

30.06.11

£m

£m

£m

£m

Residential mortgages

 4 

 - 

 4 

 6 

Corporate

 64 

 - 

 64 

 139 

Other retail lending

 31 

 (10)

 21 

 22 

Q311 IMS Appendix IV - Barclays Capital Credit Market Exposures

Barclays Capital Credit Market Exposures

 

Nine Months Ended 30.09.11

Credit market exposures1 

As at 30.09.11

As at 30.06.11

As at 31.12.10

As at 30.09.11

As at 30.06.11

As at 31.12.10

Fair Value (Losses)/ Gains and Net Funding

Impairment (Charge)/ Release

Total (Losses)/ Gains

  

$m

$m

$m

£m

£m

£m

£m

£m

£m

Protium assets2 

4,844

5,411

10,884

3,109

3,374

7,028

(507)

223 

(284)

  

US Residential Mortgages

ABS CDO Super Senior

2,918

2,949

3,085

1,873

1,839

1,992

(28)

(21)

US sub-prime and Alt-A

706

775

1,025

453

483

662

(4)

41 

37

Commercial Mortgages

Commercial real estate loans and properties

8,780

10,390

11,006

5,635

6,479

7,106

432 

432

Commercial Mortgaged Backed Securities

95

96

184

61

60

119

-

Monoline protection on CMBS

9

10

18

6

6

12

33 

33

Other Credit Market

  

Leveraged Finance3 

6,560

7,019

7,636

4,210

4,377

4,930

44 

(138)

(94)

SIVs, SIV -Lites and CDPCs

14

8

618

9

5

399

(15)

(15)

Monoline protection on CLO and other

1,904

2,000

2,541

1,222

1,247

1,641

30 

30

  

Total

25,830

28,658

36,997

16,578

17,870

23,889

(15)

133 

118 

 

- Barclays Capital's credit market exposures primarily relate to commercial real estate, leveraged finance, and collateral previously underlying the loan to Protium. These exposures arose before the market dislocation in mid-2007

- During 2011, credit market exposures decreased by £7,311m to £16,578m, reflecting net sales and paydowns and other movements of £7,197m and foreign exchange rate movements of £232m, partially offset by fair value losses and impairment releases of £118m. The net sales, paydowns and other movements of £7,197m included:

- £3,412m relating to assets formerly held as collateral for the loan to Protium Finance LLP, comprising £1,938m net sales, £959m loan and interest repayments and £515m paydowns and other movements. Of these proceeds £459m was invested in Helix, an existing fund managed by an independent asset management firm

- £1,855m of commercial real estate loans and properties sales, including £318m ($529m) to Crexus Investment Corp

 

 

 

1 As the majority of exposure is held in US Dollars, the exposures above are shown in both US Dollars and Sterling

2 Prior to 27 April 2011 when Protium was consolidated by the Group the exposure was a loan. This was carried at the amount equivalent to the fair value of the underlying collateral from 31 December 2010

3 Includes undrawn commitments of £198m (30 June 2011: £241m, 31 December 2010: £264m)

 

Protium Assets 

 

  

Acquisition Date

Acquisition Date

As at

30.09.11

As at

30.06.11

As at

27.04.11

As at

31.12.10

As at

16.09.09

As at

30.09.11

As at

30.06.11

As at

27.04.11

As at

31.12.10

As at

16.09.09

$m

$m

$m

$m

$m

£m

£m

£m

£m

£m

US sub-prime and Alt-A

1,590 

2,142 

4,406 

4,402 

4,477 

1,020 

1,335 

2,665 

2,710 

2,716 

Commercial mortgage-backed securities

2,244 

2,400 

3,092 

3,257 

1,897 

1,440 

1,497 

1,870 

2,103 

1,151 

Monoline protection

225 

4,562 

145 

2,768 

CLO and other assets

1,010 

869 

1,952 

1,636 

1,349 

649 

542 

1,181 

1,189 

818 

Total collateral

4,844 

5,411 

9,450 

9,520 

12,285 

3,109 

3,374 

5,716 

6,147 

7,453 

Cash and cash equivalents

na

na

231 

1,364 

250 

na

na

140 

881 

152 

Total assets

4,844 

5,411 

9,681 

10,884 

12,535 

3,109 

3,374 

5,856 

7,028 

7,605 

 

- On 16 September 2009, Barclays Capital sold assets of $12,285m, including $8,384m in credit market assets, to Protium. As part of the transaction, Barclays extended a $12,641m 10 year loan to Protium

- In April 2011, Barclays entered into several agreements to acquire all third party interests in Protium in order to help facilitate the Group's early exit from the underlying exposures. As a result, Protium was then consolidated by the Group. Subsequently, Protium sold its assets to Barclays entities and the loan has been repaid

- As part of this transaction, $750m was invested in Helix. The investment represented 86% of the Helix fund, which has been consolidated by the Group. The fund's investments primarily comprise government and agency securities and, as such, Helix does not represent a credit market exposure. As at 30 September 2011, the fair value of Barclays investment in the fund was $737m

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSMMBBTMBJJTMB

Related Shares:

Barclays
FTSE 100 Latest
Value10,379.08
Change-77.93